{
    "2019-01-31": [
        [
            {
                "time": "",
                "original_text": "双鹭药业炒股亏损 下修2018年利润约1亿元 投资失误",
                "features": {
                    "keywords": [
                        "双鹭药业",
                        "炒股亏损",
                        "利润下修",
                        "投资失误"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药(02196.HK)“16复药01”回售申报金额达550万元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "回售申报",
                        "16复药01",
                        "550万元"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：2018年预计增长保持稳健 荐21股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "增长稳健",
                        "荐股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒指放量收涨1.1%，博彩股领涨",
                "features": {
                    "keywords": [
                        "恒指",
                        "放量收涨",
                        "博彩股",
                        "领涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "博彩"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：利妥昔首仿将上市 国内生物类似药进度盘点",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "利妥昔首仿",
                        "生物类似药",
                        "进度盘点"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗保健",
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "港股异动︱医药股交投活跃 康哲药业(00867)升近7%",
                "features": {
                    "keywords": [
                        "港股异动",
                        "医药股",
                        "康哲药业",
                        "升近7%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【信达看盘】2019.1.31",
                "features": {
                    "keywords": [
                        "信达看盘",
                        "2019.1.31"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}